We previously reported that natural killer (NK)-sensitive target cells, K562, kill interleukin-2-stimulated (lymphokine-activated killer [LAKI) but not unstimulated NK cells. We have now investigated the molecular basis of this phenomenon. Soluble monoclonal antibody (MoAb) t o CD18 inhibited 75% of K562-induced DNA fragmentation and membrane disruption, whereas blocking MoAb to Fas partially inhibited only the DNA fragmentation. MoAbs t o CD2, CDlla, CDllb, B7, or CD16 had limited or no effect on K562-induced death of LAK cells. We have now investigated the role of adhesion molecules in K562-induced death and DNA fragmentation of L-2-activated NK cells, also known as LAK cells. We report that signaling through CD18 enables K562 to trigger membrane lysis and DNA fragmentation and that the response requires tyrosine phosphorylation and involves protease activities, We also identified the Fas-Fas-L interactions as another pathway resulting in death by apoptosis of LAK cells, but one that is probably less important in the K.562-mediated effect.
CTIVATION-INDUCED apoptosis or programmed cell
death, distinguished by certain morphologic characteristics and DNA disintegration, has been reported to regulate the function of antigen-stimulated T cells.' Natural killer (NK) cells, in contrast, appear to recycle and function repeatedly after attacking and lysing target cells: and the fate of lymphokine-activated killer (LAK) cells after interaction with target cells has not been well studied. However, evidence exists that NK cells are indeed activated after interaction with target cells. For example, interaction with NKsensitive target cells induces calcium influx and inositol phosphate generation3 and tyrosine pho~phorylation~.~ in NK cells. Adhesion molecules, including members of the p2 integrin family, appear to be involved in at least some of the signaling pathways in the activation of NK cells. Sugie et a16 reported that K562 induces activation of protein tyrosine kinases (PTK) in human NK cells through the LFA-1 (Y and p subunits, and Umehara et a17 reported phosphorylation of ,B2 integrin p chain (CD18) in NK cells in response to interleukin-2 (IL-2). Finally, we have recently reported that interaction with NK-sensitive target cells induces death by apoptosis in IL-2-activated NK or LAK cells, but not in native NK cells. 8 Certain cell surface molecules, including Fas, have been implicated in the induction of a p o p t o s i~.~~'~ Proteases have also been shown to induce apoptotic morphology" and to be required for induction of activation-induced programmed cell death'*." or apoptosis induced by cytolytic lymphoc y t e~. '~ We have now investigated the role of adhesion molecules in K562-induced death and DNA fragmentation of L-2-activated NK cells, also known as LAK cells. We report that signaling through CD18 enables K562 to trigger membrane lysis and DNA fragmentation and that the response requires tyrosine phosphorylation and involves protease activities, We also identified the Fas-Fas-L interactions as another pathway resulting in death by apoptosis of LAK cells, but one that is probably less important in the K.562-mediated effect. protein phosphorylation in LAK cells, and the tyrosine kinase inhibitor, Herbimycin A, inhibited DNA fragmentation and membrane disruption. Protease inhibitors strongly suppressed K562-mediated DNA fragmentation of LAK cells, but not membrane disruption.
A MATERIALS AND METHODS

Reagents
In conclusion, (1) K562-induced death of LAK cells involves primarily CD18, although other molecules, such as Fas, may also be involved; (2) K562-mediated apoptosis of LAK cells requires tyrosine phosphorylation and protease activity; (3) engagement of Fas by immobilized MoAb or Far-L on target cells can also kill LAK cells; and (4) Fas-immobilized MoAb synergizes with coimmobilized MoAb to CDlla, CDllb, or CD18 for LAK cell killing. Activation-induced death of NK cells may represent a mechanism for NK cell regulation. This is a US government work. There are no restrictions on its use. orthophosphate were purchased from Dupont NEN (Boston, MA). Herbimycin A (HA), Leupeptin, and phenylmethyl sulfonyl fluoride (PMSF) were from Boehringer Mannheim (Indianapolis, IN).
Antibodies and cDNAs. MoAbs to CD2 (TS2/18), CD5 (OKT-I), CDlla (TS1/22), CDllb (LM2/1), and CD18 (TS1/18) were produced from hybridomas (ATCC, Rockville, MD) as ascites in pristane-pretreated BALB/c mice and purified by precipitation in saturated (NH&S04 and passage over Sepharose protein-G sepharose beads (Pharmacia, Piscataway, NJ). Purified antibodies to CD36 (OKM5) and CD54 (ICAM-l) were obtained from Ortho Diagnostic Systems (Raritan, NJ). Purified antibody to B7-1, CD16, CD22 (Leul4). and fluorescence-tagged antibodies to CD3 (-fluorescein isothiocyanate [FITC] ), CD14(-FITC), CD16 (-FITC), CD20 (-FITC), and CD56 (-phycoerythrin [PE]) were obtained from Becton Dickinson (Mountain View, CA). Antibodies to B7-2 and tumor necrosis factor-a (TNF-a) were from Pharmingen (San Diego, CA) and Genzyme (Cambridge, MA), respectively. MoAbs (IgGI) to Fas antigen (M3 MoAb, which inhibits binding of Fas-L and induces apoptosis when immobilized, and M33 MoAb, which neither blocks ligand binding nor induces apopt~sis'".'~) and Fas-L cDNA were generously provided by Drs Mark Alderson and David Lynch (Immunex Research and Development Corp, Seattle, WA). The cDNA for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH)'' was provided by Dr Dov Pluznik (Center for Biologics Evaluation Research, Bethesda, MD). Murine IgG1, IgG2a, and IgG2b were purchased from Sigma (St Louis, MO). In preliminary tests, antibodies were titrated for effect, and 10 &mL was selected for use in all subsequent experiments, unless otherwise indicated.
Preparation of NK cells. NK cells were obtained as described previously with modification." Buffy coats, obtained from healthy donors through the National Institutes of Health Blood Bank were centrifuged over ficoll-hypaque (LSM; Organon Teknika-Cappel, Durham, NC) to obtain mononuclear cells and then over 47% Percoll (Pharmacia) to deplete the high-density lymphocytes. Cells were then incubated on plastic &shes for 1 hour to deplete monocytes. The resulting NK-enriched population was incubated for 30 minutes on ice, with antibodies to CD5, CD22, and CD36 to further deplete T cells, B cells, and monocytes, respectively; incubated with goat antimouse IgG-coated magnetic beads (Advanced Magnetics Inc, Cambridge, MA) at 4°C for 30 minutes on ice (2 cycles); and exposed to a magnetic field. The unbound, negatively selected cells were stained with fluorescence-labeled antibodies to CD3 (T cells), CD14 (monocytes), CD20 (B cells), and CD16 and CD56 (NK cells) and fluorescence was assessed on a FACScan (Becton Dickinson). NK cells (CD16' andor CD56') were always 70% to 95% pure, as verified by flow cytometric analyses. These cells were precultured with or without rIL-2 (100 U/mL) for 60 hours in RPMI 1640 medium containing 10% heat-inactivated fetal calf serum (FCS; Hyclone, Logan, UT) and 50 pg/mL of Gentamicin (Biofluids, Rockville, MD) in 5% CO, at 37°C.
Target cells. K562, an erythroblastoid cell line; U937, a histiocytic lymphoma cell line; and MOLT-4, established from a T-cell lymphoma, were used as NK-sensitive target cells. Daudi and Raji, established from B lymphomas, and UCLA-SO-M14 (M14), a human melanoma cell line,'' were used as NK-insensitive, LAK-sensitive cells. These cells were maintained in RPMI 1640 medium with 10% FCS and Gentamicin.
"Cr-release assays. The "Cr-release assay is traditionally used to measure disruption of the plasma membrane." In a reverse cytotoxicity assay, 51Cr release from NK or LAK cells was measured to examine the lysis of NK or LAK cells induced by cells normally used as targets. After preculture with or without 100 U/mL of rIL-2 or HA, NK cells were washed and incubated with 100 pCi of "Cr for 1 hour. Cells were washed twice and, importantly, aggregated cells were removed through a 70-pm nylon mesh cell strainer (Falcon/Becton Dickinson Labware, Franklin Lakes, NJ). Labeled single-cell suspensions were cocultured with nonlabeled target cells (K562, MOLT 4, U937, M14, Daudi, or Raji, or Fas-L-transfected Raji cells) in replicates of 3 to 6 wells for each culture condition in U-bottomed 96-well microtiter plates for 4 hours at 37°C. using titrated target:effector (T:E) cell ratios of 3, 0.3, and 0.03: 1. Unless otherwise indicated, data are shown for only the 3: 1 T:E ratio. Four hours was previously shown to be optimal for demonstrating membrane disruption and DNA degradation' and was used in all experiments. Spontaneous release was determined in wells containing lymphocytes in medium only, and total release was determined in wells containing lymphocytes in 1 N HCl. In some assays, antibodies or other reagents were added 30 minutes before coculture. Supernatants were harvested (Skatron, Sterling, VA) and counted in a y-counter. The percentage of lysis was calculated from the following formula: % Lysis = (Experimental Release -Spontaneous Release in the Absence of Nonlabeled Targets)/(Total Release -Spontaneous Release).
-'H-TdR retention assay. This assay for DNA fragmentation has been used to quantify apoptosis2' and was performed as described. 21 .22 Briefly, after 56 hours of culture with IL-2, LAK cells were pulsed with 2 pCi/mL of 'H-TdR for 4 to 6 hours at 37°C. After three washes, cell aggregates were removed as described above, and single-cell suspensions were cocultured for 4 hours with target cells in the same manner as for the reverse "Cr-release assay. Cells were harvested onto glass-fiber filter-mats with a cell harvester (Skatron) and radioactivity was measured in a P-plate counter. The percentage of DNA fragmentation was calculated by the following formula:
Crosslinking of receptors on LAK cells with antibodies to Fas or integrin molecules. For "Cr-release studies, 96-well U-bottom plates were coated with antibodies (30 pUwell of a 100 pg/mL solution, ie, 3 pg/well), and cytolysis of labeled LAK cells was measured in these plates. However, cellular adhesion to the plastic substrate interfered with harvesting of cells in the 'H-TdR retention assay when plastic-immobilized antibodies to integrin molecules were examined. Therefore, antibodies were conjugated to Sepharose protein-G beads (Pharmacia) by incubation of 10 pg of antibody per SO pL of original bead suspension overnight at 4°C. Two to three microliters of the original bead suspension was conjugated, washed, and resuspended in a final volume to permit dispensing 100 pL/ well. Beads were cocultured with 'H-thymidine-labeled cells for 4 hours in 96-well plates and wells were harvested onto glass-fiber filter-mats for determination of 'H-TdR retention.
Labeling of NK cells with 3zP-orthophosphate and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. NK cells that had been cultured with or without IL-2 were precultured in phosphate-free RPMI 1640 for 30 minutes and labeled with 0.5 mCi/mL of '2P-orthophosphate for 2 hours, also in phosphatefree medium. Cells were washed 3 times and cocultured with K562 cells in standard medium for 1, 5, or 15 minutes at 37°C. Cells were lysed in lysing buffer containing 1% nonidet P-40, 250 mmol/L NaC1, 50 mmol/L Tris, 50 pmoVL p-nitrophenylguanidinobenzoate, SO pg/mL leupeptin, 50 pg/mL aprotinin, 1 mmoUL NalV04, 50 mmol/L NaF, and 5 mmoVL EDTA. Samples were boiled in SDS sample buffer and subjected to SDS-PAGE, using a 9% gel and the buffer system of Laem~nli.~' Gels were dried and bands were visualized by autoradiography.
Transfection For Northern analyses, RNA was extracted from 5 X IOb cells and analyzed as described?' The Fas-L cDNA was restricted with Bgl I1 and Sac I to obtain the probe, which was labeled by random priming.
CPm.z'.2z Raji exhibited decreased to no activity (Fig 1) . None of the cells induced DNA fragmentation in native NK cells (data not shown), confirming our previous findings. These data suggest that molecules associated with NK and LAK sensitivity of target cells may be involved in target-cell-induced apoptosis of LAK cells.
RESULTS
Apoptosis
Effects of antibodies to CD18, CD2, CD16, or Fas on K562-mediated induction of membrane disruption and DNA degradation in LAK cells. We examined the roles in K562-induced apoptosis of adhesion molecules, because they have been implicated in the IL-2-induced upregulation of NK lytic a~tivity.'-*~-~~ In addition, we tested the involvement of Fas, because it triggers apoptosis in sensitive cell^^*^' and is upregulated by IL-2 treatment of NK cells (from 10% t 2% to 55% ? 11% in purified NK cells [85% to 90%] after 3 days of IL-2 treatment). As shown in Fig 2, 75% of both DNA fragmentation and membrane disruption was abrogated by anti-CD18, whereas MoAb to CD2 marginally reduced killing and blocking MoAb (M3, IgG1) to Fas inhibited 40% of DNA fragmentation but had a negligible effect on membrane disruption. Combinations of these antibodies did not inhibit K562-mediated killing beyond the effect of anti-CD18 alone, and antibodies to CD1 l a and CD1 l b also had no effect when combined, either in the presence or absence of K562 (data not shown). Although ligation of CD16 induces apoptosis of LAK ~e l l s~' .~~ and CD28/B7 interactions are involved in NK-like a c t i v i t i e~?~.~~ neither antibodies to CD16 nor a combination of antibodies to B7-l and B7-2 blocked the K562-induced apoptosis of LAK cells (Fig 2) . These antibodies were functional because immobilized anti-CD16 lysed 15% of LAK cells and anti-B7-l and -B7-2 completely blocked binding to CD28 (data not shown), in agreement with the results of previous reports. Because TNFa kills cells by a p o p t o s i~~~ and can be membrane-bound, the effect of neutralizing antibody to TNF-a (2 to 10 pgimL) on K562-mediated killing of LAK cells was examined, but it failed to inhibit K562-mediated killing, suggesting that it is also not involved in the effect. These data suggest that, That antibody to CD18, the common / 3 chain of the p2 integrins, but not antibodies to the LY chains of these integrins, LFA-1 (CD1 la) and Mac-l (CD1 lb), blocked the target-cell induced apoptosis of LAK cells further suggested that anti-CD18 inhibited apoptosis by preventing signaling rather than by steric interference. Antibodies immobilized on plastic (for use in the "Cr assay) or on Sepharose protein-G beads (for use in the 3H-TdR assay) were therefore tested directly for their ability to induce lysis and DNA degradation of LAK cells. The data showed that anti-CD18 induced DNA fragmentation and membrane disruption of LAK cells, but antibodies to CD 1 la, CD 1 1 b, or CD2 produced no effect beyond background (Fig 3) , suggesting that signaling through CD18 is involved in K562-mediated killing of LAK cells.
Fas ligation can signal both DNA degradation and membrane disruption in LAK cells, although it has a paradoxical role in the K.562-mediated effect. Because anti-Fas (M3) partially inhibited K562-induced DNA fragmentation but did not affect membrane disruption of LAK cells (Fig 2) , and, paradoxically, Fas-L mRNA was below detectable limits in K562 by Northern blot analysis (Fig 4A) , the role of inducing effect on LAK cells (Fig l) , were transfected with Fas-L and expression was enhanced by treatment with Na butyrate" (Fig 4A) . Although untreated Fas-L-Raji induced no detectable DNA fragmentation or membrane disruption of LAK cells, Na butyrate-treated cells markedly induced these effects (Fig 4B and C) , suggesting that a threshold expression of Fas-L may be required for induction of apoptosis in LAK cells when the Fas-Fas-L pathway is the sole trigger for the killing. M3 (but not M33 control MoAb) dramatically inhibited DNA fragmentation and abrogated membrane disruption induced in LAK cells by butyratetreated Fas-L-Raji, in contrast to those induced by K562, in which M3 partially inhibited the DNA fragmentation but had no effect on membrane disruption (Fig 4D and E) . Also in contrast to K562, Fas-L-Raji cells induced lysis and DNA degradation in native NK cells, but to a reduced degree compared with LAK cells (data not shown). These data support the conclusion that Fas-L-Raji and K562 use different pathways for killing LAK cells.
In tests of receptor ligation by anti-Fas antibodies, plasticimmobilized M3, but not M33 control, induced both DNA fragmentation (45% ? 4%, by 3H-TdR retention) and membrane disruption (50% 2 3%, by "Cr-release assay) of LAK cells. Finally, although M3 anti-Fas MoAb immobilized on Sepharose protein-G beads had only a marginal effect, when Fas was coligated with CD18 or with CD1 l a or CD1 l b using antibodies coimmobilized on Sepharose protein-G beads, a synergistic induction of DNA fragmentation was observed (Fig 5) . These data confirm that engagement of Fas can also induce apoptosis in LAK cells. They further suggest that a different mechanism(s) may be involved than that used when p2 integrin molecules are ligated and that coexpression of multiple membrane receptors may produce enhanced apoptosis of LAK cells.
PTK activation in K562-induced apoptosis of LAK cells. To understand the intracellular events after coculture of LAK cells with K562 cells, we first assessed whether protein kinases were activated. Whole cell lysates from 32P-orthophosphate-labeled LAK cells cocultured with K562 cells were resolved by SDS-PAGE and the results showed the induction of phosphoproteins of 42,48,50, and 90 kD within I minute (Fig 6) . It is interesting that a phosphoprotein of about 92 kD disappeared, perhaps representing dephosphorylation and concomitant reduction in apparent molecular weight to 90 k D . We then precultured LAK cells with HA, a specific inhibitor of src family protein tyrosine kinases, at 0.3 pg/ mL and 1 pg/mL in 0.1% dimethyl sulfoxide (DMSO) or DMSO alone (0.1%) for 20 hours to evaluate the contribution of this family of tyrosine kinases. After washing, LAK cells were radiolabeled and used in "Cr-release and 'H-TdR retention assays. HA significantly reduced or abrogated membrane disruption and DNA degradation in LAK cells in a dose-dependent fashion, as compared with the DMSO control (Fig 7) . These findings suggest that activation of src family protein tyrosine kinases is required for K562-mediated apoptosis of LAK cells.
Serine or cysteine proteases are involved in DNA frugmentation in apoptosis of LAIC cells induced by K562. Because some apoptosis-inducing pathways have been reported to involve serine or cysteine protease activities,12," we examined the involvement of proteases in the K562-induced apoptosis of LAK cells. Leupeptin, an inhibitor of cysteine proteases or PMSF, an inhibitor of serine protease was added to the 4 hours of coculture of isotopically labeled LAK cells with K562 at concentrations of 200, 60, or 20 pnol/L. DNA fragmentation of LAK cells, as assessed by 'H-TdR retention, was significantly inhibited in a dose-dependent fashion by either leupeptin or PMSF, whereas, in contrast, leupeptin only marginally affected the "Cr-release and PMSF had no effect (Table l) . These results indicate that the protease activity was required for the K562-mediated apoptosis of LAK cells.
DISCUSSION
Apoptosis has received a great deal of attention for its role in regulating the number of both immature and mature lympho~ytes.~.~',~~ Immature T cells undergo negative selection in the thymus through apoptosis,40 and activation-dependent apoptosis of differentiated antigen-specific CD4+ T cells regulates functional expression of antigen-specific mature T cells.'34' In contrast to T cells, NK cells do not usually recognize targets cells in a strictly antigen-specific fashion, thereby presumably enabling a first line of defense quickly and without antigen presentation. Moreover, they appear to recycle their lytic activity after lysing sensitive target c e k 2 However, similar to T cells, NK cells can be activated by target cells:4 and our earlier data have suggested that this activation may result in death of a proportion of IL-2-activated NK (LAK) cells, but not native NK cells, with the characteristics of apoptosis,' a phenomenon that may be analogous to the activation-induced cell death of mature T For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 
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Antibodies to Fas cells. We have now confirmed this observation and investiapoptosis in LAK cells was associated with their NK sensigated the mechanism(s) of K562-induced apoptosis of LAK tivity in standard "Cr-release assays, suggesting that cell cells using "Cr-release to indicate cell membrane disruption surface components may be important for the death by and 'H-TdR retention to measure DNA fragmentation.
apoptosis of LAK cells induced by target cells. Because we Our data showed that the ability of target cells to induce and many others have shown that leukocyte integrins are
involved in signaling pathways in N K cells and are activated in IL-2-stimulated NK cell^,"^^"^"^ we examined the involvement of LFA-I and Mac-I in the converse phenomenon, K562-induced killing of LAK cells. Antibody to CD18, the common p chain of these integrins, strongly inhibited both lysis of LAK cells (as indicated by "Cr-release) and DNA fragmentation (as indicated by 'H-TdR retention). Antibodies to CD1 l a and CD1 lb. two a chains used by the 0: integrins, had no effect. Together with the finding that immobilized antibodies to CD I8 induced membrane disruption and DNA fragmentation in LAK cells directly, this suggested that anti-CD18 blocked signaling through CD18, rather than simply interfering through steric hinderance with the engagement of receptor by ligand on target cells. Our experiments did not encompass an exhaustive test of the involvement of all integrins or adhesion molecules; thus, it is possible that pz integrins may be a model for the involve- -1) on protein-G sepharose beads, a synergistic signal was transduced such that similar levels of LAK cell apoptosis were induced as by K562. Therefore. although anti-Fas failed to block K562-mediated membrane disruption and Fas-L mRNA was below detectable levels in K562 cells, we cannot exclude a role for Fasmediated intracellular signaling in the K562 effect. The possibility of interaction between cell surface molecules such required for induction of activation-induced programmed cell and are important, if not required, for the induction of apoptosis induced by cytolytic cells using the granule exocytosis/perforin p a t h~a y , '~,~~-~~ we investigated their involvement in the K562-induced apoptosis of LAK cells. In the current system, K562-mediated apoptosis of LAK cells was abrogated by cysteine-or serine-protease inhibitors in the 4 hours coculture, supporting the role of proteases in the induction of apoptosis. Voelkel-Johnson et aI5' have reported that TNF-a-induced apoptosis involves protease activity. However, neutralizing antibody to TNFa had no effect on the K562-induced DNA fragmentation, indicating that TNF-a is not involved in the K562-induced effect on LAK cells.
In summary, we have investigated the K562-induced death of IL-2-activated NK cells. This activation-associated cell death involves membrane disruption and DNA disintegration of LAK cells induced by NK-sensitive targets. The mechanism involves signaling through integrins and requires src family FTK and protease activities. Engagement of other cell surface molecules, such as Fas, may also trigger LAK cell death by apoptosis under the appropriate conditions. Killing of IL-2-activated NK cells exhibits similarities with other activation-induced apoptosis systems, suggesting that the pathways delineated here may be relevant to other forms of ligand-mediated apoptosis and may represent a mechanism for NK cell regulation. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
